Skip to main content
A

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,282 across all filing types
Latest filing 2025-04-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2024年度独立董事述职报告-叶忠明(离任)
Regulatory Filings
2025-04-17 Chinese
安图生物2024年度审计报告
Regulatory Filings
2025-04-17 Chinese
安图生物2024年年度报告
Regulatory Filings
2025-04-17 Chinese
关于对安图生物控股股东及其他关联方占用资金情况的专项说明
Regulatory Filings
2025-04-17 Chinese
安图生物2024年度社会责任报告
Regulatory Filings
2025-04-17 Chinese
安图生物2025年第一季度报告
Regulatory Filings
2025-04-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.